E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/21/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: BioSphere Medical secures $14.5 million from private placement of shares

By Sheri Kasprzak

New York, Feb. 21 - BioSphere Medical, Inc. said it is gearing up to close a $14,525,000 private placement.

The company will sell 2,075,000 shares at $7.00 each to a group of institutional investors.

The offering is slated to close Feb. 22.

Based in Rockland, Mass., BioSphere is a medical device company focused on developing bio-engineered microspheres used to treat uterine fibroids, hypervascular tumors and vascular malformations.

Issuer:BioSphere Medical, Inc.
Issue:Stock
Amount:$14,525,000
Shares:2,075,000
Price:$7.00
Warrants:No
Agreement date:Feb. 17
Settlement date:Feb. 22
Stock symbol:Nasdaq: BSMD
Stock price:$7.63 at close Feb. 17

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.